Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jia-Ren Lin

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Science Translational Medicine|February 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVeronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell Systems|December 5, 2017
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to PerturbationsAlexandra B Keenan, Sherry L Jenkins, Kathleen M Jagodnik, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Science Translational Medicine|February 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVeronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell Systems|December 5, 2017
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to PerturbationsAlexandra B Keenan, Sherry L Jenkins, Kathleen M Jagodnik, et al.
Pageof 8